What Is a Medical Breakthrough Worth if Patients Can’t Get It?
HealthSpark, Episode 31: Jeff Levin-Scherz, Assistant Professor in the Department of Health Policy and Management at Harvard T.H. Chan School of Public Health and Harvard Medical School, explores the promise of GLP-1 medications and the challenges that determine who can benefit from them.
What turns a scientific advance into a public health breakthrough
Few therapies deliver benefits across several serious conditions at once. Medicines that help control blood sugar and weight have also been shown to sharply reduce the risk of developing diabetes in people with prediabetes and to reduce heart attacks and strokes. Because these benefits span connected chronic conditions, the potential impact on population health is substantial. But clinical promise alone does not determine a therapy’s broader impact; access matters, too.
Who decides which treatments people can access?
Public and private payers help determine which treatments are covered, for whom, and at what cost to patients. Their decisions balance potential health benefits against prices, eligibility rules, and competing priorities. How a condition is understood can also influence these decisions. When a chronic metabolic disease like obesity is seen as a personal failing, it can be easier to justify leaving its treatment out of coverage. Limited competition can keep prices high, and as coverage tightens, patients may need to pay out of pocket. This ties access to income.
Should we expect new therapies to pay for themselves?
A treatment can improve health substantially without reducing total medical spending, and that is the norm rather than the exception: very few patented medicines have ever lowered overall costs. Instead, a treatment's value lies in longer, healthier lives at a price society considers reasonable. To judge whether a price is reasonable, decision-makers look at two things: how much health a treatment delivers for its cost, and whether payers can afford it for everyone who might benefit. How health systems answer these questions for today’s breakthroughs will set the pattern for the next generation of high-cost, high-value therapies.
Key question to take forward:
As you watch the video and consider your own setting, you might reflect on:
How should the cost of a promising therapy be weighed against the health benefits it may bring, and who should bear that cost?
Sign Up to Receive HealthSpark Weekly